Opus Genetics (IRD) Research & Development (2010 - 2026)
Opus Genetics (IRD) reported Research & Development of $10.6 million for Q1 2026, up 32.99% year-over-year from $8.0 million in Q1 2025, and up 1.43% on a QoQ basis from $10.4 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Research & Development data on file, last reported at $10.6 million in Q1 2026.
- Quarterly Research & Development rose 32.99% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.4 million (up 11.25% YoY) and the FY2025 annual result came in at $30.8 million, up 14.75% from the prior year.
- Research & Development grew to $10.6 million in Q1 2026 per IRD's latest filing, from $10.4 million in the prior quarter.
- Across five years, Research & Development topped out at $10.6 million in Q1 2026 and bottomed at $2.8 million in Q3 2022.
- The 5-year median for Research & Development is $5.6 million (2023), against an average of $5.9 million.
- The widest annual swing landed in 2024, when Research & Development jumped 157.07%; it then fell 28.65% in 2025.
- Tracing IRD's Research & Development over 5 years: stood at $3.6 million in 2022, then advanced by 7.11% to $3.8 million in 2023, then soared by 83.13% to $7.0 million in 2024, then surged by 48.25% to $10.4 million in 2025, then climbed by 1.43% to $10.6 million in 2026.
- Per Business Quant, the three latest IRD Research & Development figures stand at $10.6 million (Q1 2026), $10.4 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 10.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.58 Mn |
| Dec 31, 2025 | 10.43 Mn |
| Sep 30, 2025 | 6.41 Mn |
| Jun 30, 2025 | 6.02 Mn |
| Mar 31, 2025 | 7.95 Mn |
| Dec 31, 2024 | 7.03 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 6.09 Mn |
| Mar 31, 2024 | 4.75 Mn |
| Dec 31, 2023 | 3.84 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 4.72 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 3.59 Mn |
| Sep 30, 2022 | 2.84 Mn |
| Jun 30, 2022 | 3.16 Mn |
| Mar 31, 2022 | 4.77 Mn |
| Dec 31, 2021 | 4.74 Mn |
| Sep 30, 2021 | 3.13 Mn |
| Jun 30, 2021 | 3.83 Mn |
| Mar 31, 2021 | 3.48 Mn |
| Dec 31, 2020 | 4.34 Mn |
| Sep 30, 2020 | 1.38 Mn |
| Jun 30, 2020 | 711,000.00 |
| Mar 31, 2020 | 218,000.00 |
| Dec 31, 2019 | -2.65 Mn |
| Sep 30, 2019 | 1.13 Mn |
| Jun 30, 2019 | 1.65 Mn |
| Mar 31, 2019 | 2.24 Mn |
| Dec 31, 2018 | 2.73 Mn |
| Sep 30, 2018 | 2.89 Mn |
| Jun 30, 2018 | 3.43 Mn |
| Mar 31, 2018 | 4.06 Mn |
| Dec 31, 2017 | 3.26 Mn |
| Sep 30, 2017 | 2.64 Mn |
| Jun 30, 2017 | 2.54 Mn |
| Mar 31, 2017 | 2.26 Mn |
| Dec 31, 2016 | 2.08 Mn |
| Sep 30, 2016 | 2.30 Mn |
| Jun 30, 2016 | 2.24 Mn |
| Mar 31, 2016 | 3.47 Mn |
| Dec 31, 2015 | 2.92 Mn |
| Sep 30, 2015 | 3.10 Mn |
| Jun 30, 2015 | 3.24 Mn |
| Mar 31, 2015 | 2.89 Mn |
| Dec 31, 2014 | 2.22 Mn |
| Sep 30, 2014 | 1.82 Mn |
| Jun 30, 2014 | 1.70 Mn |
| Mar 31, 2014 | 1.27 Mn |
| Dec 31, 2013 | 994,262.00 |
| Sep 30, 2013 | 781,281.00 |
| Jun 30, 2013 | 925,130.00 |
| Mar 31, 2013 | 552,466.00 |
| Dec 31, 2012 | 265,695.00 |
| Sep 30, 2012 | 1.07 Mn |
| Jun 30, 2012 | 1.02 Mn |
| Mar 31, 2012 | 1.04 Mn |
| Dec 31, 2011 | 1.49 Mn |
| Sep 30, 2011 | 2.37 Mn |
| Jun 30, 2011 | 5.42 Mn |
| Mar 31, 2011 | 2.72 Mn |
| Dec 31, 2010 | 1.48 Mn |
| Sep 30, 2010 | 671,339.00 |
| Jun 30, 2010 | 1.33 Mn |